Best for
Mobile

Posted
Aida Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Aida Pharmaceuticals shares (AIDA.US) are listed on the PINK and all prices are listed in US Dollars. Aida Pharmaceuticals employs 450 staff and has a trailing 12-month revenue of around $40.5 million.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Latest market close | $N/A |
---|---|
52-week range | $0.0104 - $0.15 |
50-day moving average | $0.0222 |
200-day moving average | $0.0455 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.081 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing Aida Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aida Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aida Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.5 million.
The EBITDA is a measure of a Aida Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $40.5 million |
---|---|
Operating margin TTM | 17.34% |
Gross profit TTM | $14.6 million |
Return on assets TTM | 6.62% |
Return on equity TTM | -1.79% |
Profit margin | -5.38% |
Book value | $0.339 |
Market capitalisation | $8.4 million |
TTM: trailing 12 months
We're not expecting Aida Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Aida Pharmaceuticals's shares were split on a 5:4 basis on 30 November 2005. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Aida Pharmaceuticals shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Aida Pharmaceuticals shares which in turn could have impacted Aida Pharmaceuticals's share price.
Over the last 12 months, Aida Pharmaceuticals's shares have ranged in value from as little as $0.0104 up to $0.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Aida Pharmaceuticals's is -2.2526. This would suggest that Aida Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aida Pharmaceuticals has bucked the trend.
Subscribe to trending stock alerts for a chance to win
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.